Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Delphine Casabonne; Yolanda Benavente; Julia Seifert; Laura Costas; María Armesto; María Arestin; Caroline Besson; Fatemeh Hosnijeh; Eric J. Duell; Elisabete Weiderpass; Giovanna Masala; Rudolf Kaaks; Federico Canzian; María‐dolores Chirlaque; Vittorio Perduca; Francesca Mancini; Valeria Pala; Antonia Trichopoulou; Anna Karakatsani; Carlo La Vecchia; Maria‐jose Sánchez; Rosario Tumino; Marc J Gunter; Pilar Amiano; Salvatore Panico; Carlotta Sacerdote; Julie Schmidt; Heiner Boeing; Matthias B Schulze; Aurelio Barricarte; Elio Riboli; Anja Olsen; Anne Tjonneland; Roel Vermeulen; Alexandra Nieters; Charles Lawrie; Silvia Sanjosé

doi:10.1002/ijc.32894

Journal articles

Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Delphine Casabonne ¹ Yolanda Benavente ² Julia Seifert Laura Costas ³ María Armesto María Arestin Caroline Besson ^{4, 5, 6, 7} Fatemeh Hosnijeh Eric J. Duell ⁸ Elisabete Weiderpass ⁹ Giovanna Masala ¹⁰ Rudolf Kaaks ¹¹ Federico Canzian ¹² María‐dolores Chirlaque Vittorio Perduca ^{13, 5, 4} Francesca Mancini ^{5, 6, 14} Valeria Pala ¹⁵ Antonia Trichopoulou ¹⁶ Anna Karakatsani ¹⁷ Carlo La Vecchia ¹⁸ Maria‐jose Sánchez Rosario Tumino ¹⁹ Marc J Gunter ²⁰ Pilar Amiano ¹ Salvatore Panico ²¹ Carlotta Sacerdote ²² Julie Schmidt Heiner Boeing ²³ Matthias B Schulze ²⁴ Aurelio Barricarte ¹ Elio Riboli ²⁵ Anja Olsen ²⁶ Anne Tjonneland ²⁷ Roel Vermeulen ²⁸ Alexandra Nieters ²⁹ Charles Lawrie Silvia Sanjosé

1 CIBER de Epidemiología y Salud Pública (CIBERESP)

2 Catalan Institute of Oncology (ICO-IDIBELL)

3 Facultat de Medicina [Barcelona]

4 CHV - Centre Hospitalier de Versailles André Mignot

5 CESP - Centre de recherche en épidémiologie et santé des populations

6 IGR - Institut Gustave Roussy

7 U1018 (Équipe 3) - Épidémiologie des radiations, épidémiologie clinique des cancers et survie

IGR - Institut Gustave Roussy : U1018 (eq.3), CESP - Centre de recherche en épidémiologie et santé des populations

8 Unit of Nutrition, Environment, and Cancer

9 Department of Community Medicine, Faculty of Health Sciences

10 Cancer Risk Factors and LifeStyle Epidemiology Unit

11 Division of Cancer Epidemiology

12 Department of Cancer Epidemiology

13 MAP5 - UMR 8145 - Mathématiques Appliquées Paris 5

14 U1018 (Équipe 9) - Mode de vie, génétique et santé : études intégratives et transgénérationnelles

IGR - Institut Gustave Roussy, CESP - Centre de recherche en épidémiologie et santé des populations

15 Epidemiology and Prevention Unit

16 WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health

Dept of Hygiene, Epidemiology and Medical Statistics

17 Hellenic Health Foundation

18 Department of Clinical Sciences and Community Health [Milan, Italy]

19 Civile - M.P.Arezzo Hospital

20 Nutrition and Metabolism Section

21 Department of Clinical and Experimental Medicine

22 CPO Piemonte

23 Department of Epidemiology

24 DIfE - German Institute of Human Nutrition Potsdam-Rehbrücke

25 Faculty of Medicine - School of Public Health [London, UK]

26 Danish Cancer Society Research Center

27 Danish Cancer Society

28 Division of Environmental Epidemiology

29 Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, Freiburg, Germany

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Santé publique et épidémiologie

Complete list of metadata

https://hal-univ-paris.archives-ouvertes.fr/hal-02872360
Contributor : Vittorio Perduca Connect in order to contact the contributor
Submitted on : Wednesday, June 17, 2020 - 5:38:21 PM
Last modification on : Wednesday, November 30, 2022 - 4:14:07 PM

Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Links full text

Identifiers

Collections

Citation

Export

Metrics

37

Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

37